Relationship Between Tracheal and Left Pulmonary Artery Stenosis Index and Prognosis of PA Sling With Tracheal Stenosis

Relationship Between Tracheal and Left Pulmonary Artery Stenosis Index and Prognosis of Pulmonary Artery Sling With Tracheal Stenosis

Pulmonary artery sling is a rare congenital pulmonary vascular malformation, often associated with tracheal or bronchial stenosis. Surgical treatment of pulmonary artery sling with tracheal stenosis has a high risk and a relatively poor prognosis. This article aims to explore the relationship between the index of tracheal and left pulmonary artery stenosis and the surgical effect of pulmonary artery sling with tracheal stenosis. Methods: Retrospective analysis of the cases of pulmonary artery sling surgery in our center from January 2010 to December 2018. Before operation, routine cardiac enhancement CT examination was performed, and the diameter of the left pulmonary artery and the tracheal stenosis were measured on the CT tomogram respectively, and the ratio of the degree of tracheal stenosis / left pulmonary artery stenosis (T / P) was calculated, combining the surgical method and clinical prognosis analyzed and discussed.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Pulmonary artery sling is a rare congenital pulmonary vascular malformation. The abnormality of the left pulmonary artery originates from the right pulmonary artery instead of the trunk of the pulmonary artery. It passes around the trachea, passes between the trachea and the esophagus, and forms a vascular ring with the arterial ligament. Compression of the trachea and esophagus, especially the symptoms of tracheal stenosis caused by the compression of the trachea, can be manifested as serious symptoms such as respiratory infections, wheezing, and even respiratory distress, which can be life-threatening in severe cases. Therefore, the key to the surgical treatment of pulmonary artery sling is to relieve tracheal compression and correct tracheal stenosis, which is also the difficulty. At present, the overall survival rate of surgical treatment of pulmonary artery sling around the world is about 78% to 93% [1], but the mortality rate for patients with severe tracheal stenosis is also high, reaching about 24% [1], mainly due to pre-operative or post-operative respiratory failure caused by narrowed trachea. At present, the selection and intervention of pulmonary artery sling combined with tracheal stenosis is still a difficult problem. On the one hand, if tracheoplasty is performed, anastomotic scar hyperplasia after surgery may lead to local tracheal stenosis again [2], and long-term care is also quite difficult; If tracheoplasty is not performed, tracheal stenosis may not be completely relieved, and obstructive ventilation disorder and respiratory failure may occur after surgery [1]. At present, there is basically no objection to the preoperative assessment methods of pulmonary artery sling. CCTA is generally considered to be an effective method for diagnosing pulmonary artery sling with tracheal stenosis. It can display abnormally deformed pulmonary arteries and narrowed trachea, and it can also detect intracardiac malformations. The important means of preoperative evaluation can also be used for postoperative evaluation [3].

There is currently no consensus on the indications for tracheal intervention with pulmonary artery sling combined with tracheal stenosis. Some researchers believe that tracheoplasty should be performed for tracheal diameters less than 3mm, or the prognosis is poor [4]. Some researchers have suggested that the diameter / length percentage of tracheal stenosis can be used as a reference index for intervention of tracheal stenosis [5]. Brouns et al. found that the square of the cross-sectional area of the tracheal stenosis has a significant proportional relationship with the air flow, so they believe that the cross-sectional area of the tracheal stenosis is the main factor affecting the ventilation effect [6]. When I reviewed the imaging data of children with tracheal stenosis in our center, the most severe tracheal stenosis is usually located in the vascular ring formed by the right pulmonary artery starting segment, the left pulmonary artery starting segment, and the left pulmonary artery bypass segment. Not only was the trachea compressed and significantly narrowed, but the left pulmonary artery was also significantly narrowed, that is, the trachea and the left pulmonary artery were squeezed together in a limited space, causing both of them to be compressed and narrowed. This study was the first to investigate the interaction and morphological changes of the trachea and the left pulmonary artery, and the ratio of the degree of tracheal stenosis / left pulmonary artery stenosis (T / P) was used to indicate the degree of interaction between the two. A larger T / P ratio indicates that the left pulmonary artery is more dominant in tracheal compression, and tracheal stenosis is usually more serious. On the contrary, a smaller T / P ratio indicates that the trachea is more dominant in compression of the left pulmonary artery, and the tracheal stenosis is usually relatively lighter. This article retrospectively analyzes the cases in our center and discusses the effects of surgical treatment.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 201102
        • Children's Hospital of Fudan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients with tracheoplasty and left pulmonary artery transplantation at the same time, and only with left pulmonary artery transplantation

Description

Inclusion Criteria: surgical cases of pulmonary artery sling operated in our center from January 2010 to December 2018 -

Exclusion Criteria:cases of pulmonary artery sling without opertion

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
TRACHEAL FORMING GROUP
Left pulmonary artery transplantation and slide tracheoplasty
tracheoplasty and only left pulmonary artery transplantation
NON-TRACHEAL FORMING GROUP
only Left pulmonary artery transplantation
tracheoplasty and only left pulmonary artery transplantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of tracheal forming group and non-tracheal forming group
Time Frame: 30 days
Tracheal stenosis (T) and left pulmonary artery stenosis (P) ratio were compared between the two groups
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2010

Primary Completion (Actual)

December 30, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

May 7, 2020

First Submitted That Met QC Criteria

May 7, 2020

First Posted (Actual)

May 12, 2020

Study Record Updates

Last Update Posted (Actual)

May 12, 2020

Last Update Submitted That Met QC Criteria

May 7, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anomalies of Pulmonary Artery, Congenital

3
Subscribe